Villers-le-Bouillet, Belgium
Cryopreservation Center
Villers-le-Bouillet, Belgium Cryopreservation Center
Standardized Cryopreservation, Purpose-Built for Cell Therapy
Cryoport Systems’ Villers-le-Bouillet facility is advancing the standardization and scalability of cryopreservation across the global cell therapy landscape. With over 13,000 square feet of specialized operational space, this site is the first in Europe to offer IntegriCell™ cryopreservation as a service, bringing a new level of consistency and compliance to the preservation of critical cellular starting materials.
Built to address a longstanding gap in therapy manufacturing workflows, Villers-le-Bouillet enables sponsors, CROs, CDMOs, and clinical sites to implement harmonized cryopreservation protocols designed to preserve cell viability and reduce manufacturing variability, with GMP-compliant workflows and expert handling designed specifically for cell and gene therapy applications (including dedicated cryopreservation process development and optimization support).
From our Veri-Clean® process to robust requalification of shipping systems before every use, Cryoport Systems sets the standard for quality and safety in the temperature-controlled supply chain.
Key Capabilities at the Villers-le-Bouillet Cryopreservation Center
IntegriCell™ Cryopreservation Service
- Controlled cryopreservation of leukapheresis and other cell-based starting material
- Cryopreservation process development services to support optimization of cell handling protocols prior to scale-up or commercialization
- Personnel trained under GMP-like procedures and process documentation
- Scalable model supporting multi-center studies and global supply continuity
- Central location within the EU for efficient access to major biopharma hubs
- Integrated with Cryoport Systems’ global supply chain platform and logistics network
Preserving the Future of Medicine Starts Here
Integrated with our full, end-to-end supply chain platform
The Villers-le-Bouillet Cryopreservation Center is engineered to meet the evolving demands of cell therapy development, offering a repeatable and scalable cryopreservation process that protects the most sensitive material in the supply chain: the starting cells.
As part of IntegriCell™ cryopreservation services, this facility helps sponsors bridge the variability gap between clinical collection sites and manufacturing environments. Rather than relying on site-specific or ad hoc freezing methods, clients can cryopreserve closer to the point of collection with confidence, knowing that Cryoport Systems’ infrastructure and quality oversight extend across continents.
Enabling Success for EU-Based Cell Therapy Programs
Strategically located in Belgium, Villers-le-Bouillet enhances Cryoport Systems’ ability to support advanced therapy programs across Europe. From early-phase trials to commercial therapy distribution, the Villers-le-Bouillet Cryopreservation Center offers a trusted foundation for ensuring product consistency, patient safety, and regulatory confidence, delivered with the precision and partnership Cryoport Systems is known for.
